Clinical Trial Update: Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent Sarcomas [Phase 2]

View source ↗

Summary

Phase 2 trial of sunitinib in metastatic, locally advanced, or locally recurrent sarcomas completed; results posted in 2016 and include desmoid-type fibromatosi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Desmoid-type Fibromatosis
• Endometrial Cancer
• Ovarian Cancer
• Sarcoma
• Small Intestine Cancer
• Undifferentiated Pleomorphic Sarcoma of Bone

Drugs mentioned

• Sutent (sunitinib)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Adult Malignant Fibrous Histiocytoma of Bone, Desmoid Tumor | Phase 2 | Status: COMPLETED | Results posted: 2016-01-20